Skip to content

Boston Scientific BSX Amount that if recognized, would affect the effective tax rate or regulatory liability

Amount that if recognized, would affect the effective tax rate or regulatory liability at other companies

Abbott logo
AbbottABT
Edwards Lifesciences logo
Edwards LifesciencesEW
Medtronic logo
MedtronicMDT
Cardinal Health logo
Cardinal HealthCAH

Other financials

Income statement

See full
Revenue$5.2B+11.6%
Gross profit$3.6B+12.6%
Operating income$1.1B+19.5%
Net income$1.3B+99.3%
EPS (diluted)$0.90+100%

Balance sheet

See full
Cash & equivalents$850.0M+146%
Total equity$25.9B+16.4%
Total assets$44.4B+10.5%

Cash flow

See full
Operating cash flow$348.0M-35.7%
CapEx$177.0M-5.4%
Free cash flow$171.0M-51.7%

Valuation

See full
Market cap$67.32B-37.5%
P/E18.9×-34.3×
P/S3.3×-2.9×

Profitability

See full
Gross margin69.2%+0.5pp
Operating margin18.4%+2.2pp
Net margin17.3%+5.7pp

Returns & leverage

See full
Return on equity14.8%+5.2pp
Debt / equity-0.5×
Current ratio1.9×+0.4×

Where this comes from

Reported directly by Boston Scientific in its filing.

Tagged under the XBRL concept us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate.

The official record: Boston Scientific’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Boston Scientific's amount that if recognized, would affect the effective tax rate or regulatory liability.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Boston Scientific's amount that if recognized, would affect the effective tax rate or regulatory liability?
Boston Scientific (BSX) reported amount that if recognized, would affect the effective tax rate or regulatory liability of $512M in Q1 2026.
How has Boston Scientific's amount that if recognized, would affect the effective tax rate or regulatory liability changed year-over-year?
Boston Scientific's amount that if recognized, would affect the effective tax rate or regulatory liability increased by 18.8% year-over-year, from $431M to $512M.
What is the long-term trend for Boston Scientific's amount that if recognized, would affect the effective tax rate or regulatory liability?
Over 5 years (2020 to 2025), Boston Scientific's amount that if recognized, would affect the effective tax rate or regulatory liability has grown at a 22.3% compound annual growth rate (CAGR), from $183M to $501M.